Shelter Pharma, 543963, Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

50.17
6.93
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

47.79
1.16%
0.84

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales - 50.66 40.02 36.15 30.06 22.48 30.07 27.73 31.46 30.01 28.14 Net Sales Growth - 26.59% 10.71% 20.26% 33.72% -25.24% 8.44% -11.86% 4.83% 6.65% Cost Of Goods Sold - 37.03 28.92 26.25 25.85 21.14 28.30 25.70 29.22 28.73 26.34 Gross Profit - 13.63 11.10 9.90 4.21 1.34 1.77 2.03 2.24 1.27 1.80 GP Margin - 26.90% 27.74% 27.39% 14.01% 5.96% 5.89% 7.32% 7.12% 4.23% 6.40% Total Expenditure - 40.60 31.24 28.09 27.32 22.29 29.82 27.55 31.30 30.70 27.98 Power & Fuel Cost - 0.08 0.07 0.06 0.05 0.05 0.07 0.07 0.07 0.06 0.05 % Of Sales - 0.16% 0.17% 0.17% 0.17% 0.22% 0.23% 0.25% 0.22% 0.20% 0.18% Employee Cost - 1.22 0.63 0.45 0.35 0.33 0.39 0.39 0.52 0.47 0.43 % Of Sales - 2.41% 1.57% 1.24% 1.16% 1.47% 1.30% 1.41% 1.65% 1.57% 1.53% Manufacturing Exp. - 0.23 0.24 0.27 0.16 0.16 0.25 0.35 0.41 0.35 0.15 % Of Sales - 0.45% 0.60% 0.75% 0.53% 0.71% 0.83% 1.26% 1.30% 1.17% 0.53% General & Admin Exp. - 1.26 0.70 0.56 0.56 0.58 0.75 0.85 0.91 0.84 0.86 % Of Sales - 2.49% 1.75% 1.55% 1.86% 2.58% 2.49% 3.07% 2.89% 2.80% 3.06% Selling & Distn. Exp. - 0.23 0.22 0.10 0.04 0.06 0.07 0.18 0.15 0.18 0.15 % Of Sales - 0.45% 0.55% 0.28% 0.13% 0.27% 0.23% 0.65% 0.48% 0.60% 0.53% Miscellaneous Exp. - 0.56 0.45 0.39 0.31 -0.02 0.00 0.01 0.03 0.07 0.15 % Of Sales - 1.11% 1.12% 1.08% 1.03% -0.09% 0% 0.04% 0.10% 0.23% 0% EBITDA - 10.06 8.78 8.06 2.74 0.19 0.25 0.18 0.16 -0.69 0.16 EBITDA Margin - 19.86% 21.94% 22.30% 9.12% 0.85% 0.83% 0.65% 0.51% -2.30% 0.57% Other Income - 0.02 0.01 0.00 0.02 0.01 0.01 0.02 0.01 0.83 0.00 Interest - 0.13 0.26 0.03 0.08 0.02 0.01 0.00 0.00 0.01 0.01 Depreciation - 0.27 0.25 0.16 0.17 0.12 0.13 0.12 0.10 0.07 0.10 PBT - 9.68 8.28 7.88 2.51 0.06 0.11 0.08 0.07 0.06 0.05 Tax - 2.44 2.08 1.78 0.67 0.02 0.03 0.02 0.01 0.01 0.01 Tax Rate - 25.21% 25.12% 25.50% 26.69% 33.33% 27.27% 25.00% 14.29% 16.67% 20.00% PAT - 7.24 6.20 5.21 1.84 0.04 0.08 0.06 0.05 0.05 0.05 PAT before Minority Interest - 7.24 6.20 5.21 1.84 0.04 0.08 0.06 0.05 0.05 0.05 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 14.29% 15.49% 14.41% 6.12% 0.18% 0.27% 0.22% 0.16% 0.17% 0.18% PAT Growth - 16.77% 19.00% 183.15% 4,500.00% -50.00% 33.33% 20.00% 0.00% 0.00% EPS - 6.24 5.34 4.49 1.59 0.03 0.07 0.05 0.04 0.04 0.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 42.72 35.82 14.55 8.93 7.11 6.98 7.69 7.63 7.78 7.77 Share Capital 11.56 11.56 7.74 0.48 0.48 0.45 0.45 0.45 0.45 0.45 Total Reserves 31.16 24.26 6.80 8.44 6.63 6.53 7.23 7.17 7.32 7.31 Non-Current Liabilities 0.95 0.59 0.65 0.20 0.19 0.18 0.10 0.10 0.10 0.06 Secured Loans 0.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.37 0.57 0.48 0.06 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.05 0.05 0.05 0.04 0.09 0.08 0.00 0.00 0.00 0.00 Current Liabilities 4.63 4.98 6.25 3.71 2.90 3.47 3.21 3.08 3.76 3.73 Trade Payables 1.25 0.71 0.47 0.32 0.31 0.26 0.19 0.15 0.17 0.18 Other Current Liabilities 0.07 0.06 2.62 2.69 2.53 2.92 2.74 2.55 2.84 0.82 Short Term Borrowings 0.11 0.00 1.30 0.04 0.00 0.24 0.16 0.07 0.11 2.07 Short Term Provisions 3.20 4.20 1.85 0.65 0.06 0.05 0.13 0.31 0.65 0.66 Total Liabilities 48.30 41.39 21.45 12.84 10.20 10.63 11.00 10.81 11.64 11.56 Net Block 5.96 3.58 1.85 1.45 1.57 1.77 2.69 2.67 2.71 2.61 Gross Block 8.36 5.70 3.72 3.17 3.12 3.11 3.51 3.37 3.31 3.28 Accumulated Depreciation 2.39 2.13 1.88 1.72 1.55 1.34 0.82 0.70 0.60 0.67 Non Current Assets 15.03 8.16 2.73 3.01 2.32 2.57 3.37 3.06 3.02 2.76 Capital Work in Progress 0.00 0.00 0.00 0.55 0.00 0.00 0.22 0.13 0.11 0.14 Non Current Investment 0.68 0.68 0.68 0.68 0.68 0.68 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 8.39 3.90 0.21 0.33 0.08 0.12 0.46 0.26 0.20 0.01 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 33.28 33.22 18.72 9.83 7.88 8.07 7.63 7.75 8.62 8.79 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 12.90 9.93 7.96 5.67 4.02 4.31 4.12 3.81 3.91 4.43 Sundry Debtors 9.47 8.85 8.19 1.61 0.76 0.61 0.06 0.59 1.16 1.00 Cash & Bank 3.42 5.04 0.43 0.10 0.37 0.14 0.12 0.08 0.08 0.10 Other Current Assets 7.49 0.00 0.00 0.00 2.73 3.01 3.32 3.27 3.47 3.27 Short Term Loans & Adv. 7.49 9.40 2.13 2.45 2.73 3.01 3.32 3.27 3.47 3.27 Net Current Assets 28.65 28.24 12.47 6.12 4.98 4.60 4.42 4.67 4.85 5.06 Total Assets 48.31 41.38 21.45 12.84 10.20 10.64 11.00 10.81 11.64 11.55

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 5.48 -1.96 -0.96 0.52 0.00 0.00 0.00 PBT 9.68 8.28 7.05 2.51 0.00 0.00 0.00 Adjustment 0.26 0.58 0.17 0.05 0.00 0.00 0.00 Changes in Working Capital -2.02 -9.26 -8.19 -2.04 0.00 0.00 0.00 Cash after chg. in Working capital 7.92 -0.40 -0.96 0.52 0.00 0.00 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.44 -1.56 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.13 -4.54 0.11 -0.85 0.00 0.00 0.00 Net Fixed Assets -2.66 -1.98 0.00 -0.30 0.00 -0.28 Net Investments 0.00 0.00 0.00 -0.68 0.00 0.00 Others -4.47 -2.56 0.11 0.13 0.00 0.28 Cash from Financing Activity 0.03 11.12 1.18 0.06 0.00 0.00 0.00 Net Cash Inflow / Outflow -1.62 4.61 0.33 -0.27 0.00 0.00 0.00 Opening Cash & Equivalents 5.04 0.43 0.10 0.37 0.00 0.00 0.00 Closing Cash & Equivalent 3.42 5.04 0.43 0.10 0.00 0.00 0.00

Financial Ratios

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 36.14 30.17 17.57 10.31 206.99 170.15 68.58 84.09 29.73 24.22 ROA 16.14% 19.74% 30.37% 15.94% 11.67% 12.01% 10.25% 9.94% 4.81% 8.68% ROE 18.88% 25.58% 48.22% 25.95% 19.54% 26.40% 29.81% 27.77% 20.29% 42.68% ROCE 25.07% 33.62% 59.61% 36.17% 22.50% 25.25% 26.91% 26.11% 29.22% 36.53% Fixed Asset Turnover 7.21 8.49 10.49 9.57 9.63 10.20 9.65 7.79 6.15 5.48 Receivable days 66.01 77.72 49.47 14.36 61.36 66.14 82.44 74.53 38.46 21.47 Inventory Days 82.22 81.59 68.85 58.83 73.90 46.30 27.29 28.52 26.12 27.29 Payable days 9.68 7.45 5.49 4.48 9.95 6.86 26.68 28.12 1.94 2.99 Cash Conversion Cycle 138.55 151.86 112.83 68.72 125.30 105.59 83.05 74.93 62.63 45.77 Total Debt/Equity 0.03 0.02 0.13 0.02 0.22 0.27 1.72 0.62 1.54 1.14 Interest Cover 72.95 32.42 278.06 32.60 2441.20 13.03 5.01 3.67 2.81 2.81

Annual Reports:

News Update:

Shelter Pharma bags order worth $18,300
12th Mar 2026, 16:12 PM

The order is to be executed within 6 months
Read More
Shelter Pharma expands Nutraceutical portfolio with launch of FitKick Pro powder
2nd Feb 2026, 14:08 PM

The FitKick Pro Powder provides several health benefits like explosive strength, improved endurance, enhanced focus and muscle pump
Read More
Shelter Pharma secures order from Taha Drugs & Chemicals
27th Jan 2026, 14:59 PM

The order is to be executed within 2 months
Read More
Shelter Pharma secures order worth $1,41,600
23rd Jan 2026, 12:58 PM

The said order is expected to be completed within 2 months
Read More
Shelter Pharma bags order worth $27,540
16th Dec 2025, 14:51 PM

The order is to be executed within 2 months
Read More
Shelter Pharma launches D3 CURE Capsules
15th Dec 2025, 17:47 PM

This launch is part of the Company’s strategy to expand its Nutraceutical portfolio and strengthen its presence in the wellness and preventive healthcare segment
Read More
Shelter Pharma secures order from Taha Drugs & Chemicals
12th Dec 2025, 14:51 PM

The said order is expected to be completed within 2 months
Read More

Shelter Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543963 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update:

Shelter Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543963 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update: